echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Gan Li Pharmaceuticals Phase 1 candidate drug was approved by the FDA Fast Track

    Gan Li Pharmaceuticals Phase 1 candidate drug was approved by the FDA Fast Track

    • Last Update: 2021-03-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The one-year survival rate of glioblastoma was 39.3%.
    the second and fifth years after diagnosis, the survival rate dropped to 16.9 per cent and 5.5 per cent, respectively.
    survival time for untreated patients is only three months.
    available treatment can only improve the prognosmation for a few months.
    Note: The original text has been deleted Reference 1. Thakkar JP, et al. (2014). Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 23(10), 1-25. 2. Ostrom Q, et al. (2018). Chapter 2: Brain Metastases: Epidemiology. In Schiff ED, Van den Bent MJ, Handbook of Clinical Neurology, Vol. 149 (3rd series) Metastatic Disease of the Nervous System (pp. 27-42). Elsevier BV. 3. Fast Track, U.S. Food and Drug Administration (January 4, 2018).
    website: .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.